Demystifying the COVID-19 Vaccines
If you registered for the live event at the time, then please use the same link and access code to rewatch a recording of the live event video stream!
Anne TomalinVice President, Quality, Regulatory & Safety, Innomar Strategies
A recognized leader in Regulatory Affairs with over 40 years of experience in the pharmaceutical industry.
Dave BardPresident & Founder of EMREACH Inc.
Dave Bard is an entrepreneur, business leader and a published author. He has over twenty years of leadership experience in pharmaceutical and medical device commercial roles with leading healthcare companies in North America. Dave founded EMREACH Inc. in 2010 with the goal of helping pharma navigate and capitalize on the emerging technology of Electronic Medical Records. EMREACH has helped countless pharmaceutical marketers and patient program leads improve patient access and care by leveraging the capabilities of EMRs.
Dr. Shurjeel ChoudhriSVP and Head, Medical & Scientific Affairs, Bayer Pharmaceuticals Inc.
Dr. Choudhri is the Senior Vice President and Head of Medical and Scientific Affairs (M&SA) for Bayer Inc. Before assuming his current role, Dr. Choudhri was a Global Clinical Leader, Anti-Infectives with Bayer Global Clinical Development. Prior to joining Bayer, Dr. Choudhri was an assistant professor in the Departments of Medical Microbiology and Internal Medicine at the University of Manitoba in Winnipeg. He was also the director of the AIDS program at the St. Boniface General Hospital in Winnipeg; and the Manitoba satellite director for the Canadian HIV Clinical Trials Network. Dr. Choudhri obtained his MD from the University of Manitoba and also did his specialty training in internal medicine and sub-specialty training in infectious diseases in Manitoba. Following completion of his training, he completed a senior research fellowship in Nairobi, Kenya. In 1996, he was awarded the Young Investigator Award by the Canadian Association of HIV Researchers. Dr. Choudhri has authored or co-authored over 100 scientific abstracts and over 45 publications in peer reviewed journals. He is a passionate advocate for mobile and digital Health and for promoting Canada as a destination for clinical research.